Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Idiopathic Bence Jones Proteinuria (Smoldering Monoclonal Light-Chain Proteinuria): Clinical Course and Prognosis

Robert A. Kyle, MD, Dirk Larson, Terry M Therneau, PhD, Angela Dispenzieri, MD, Joanne T Benson, L. Joseph Melton, III, MD, S. Vincent Rajkumar, MD

Blood (2012) 120 (21): 1861.

https://doi.org/10.1182/blood.V120.21.1861.1861

Published: 2012

Journal Articles

Progression in smoldering Waldenström macroglobulinemia: long-term results

Robert A. Kyle, Joanne T. Benson, Dirk R. Larson, Terry M. Therneau, Angela Dispenzieri, Shaji Kumar, L. Joseph Melton, III, S. Vincent Rajkumar

Blood (2012) 119 (19): 4462–4466.

https://doi.org/10.1182/blood-2011-10-384768

Published: 2012

Journal Articles

Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications

Giada Bianchi, Robert A. Kyle, Colin L. Colby, Dirk R. Larson, Shaji Kumar, Jerry A. Katzmann, Angela Dispenzieri, Terry M. Therneau, James R. Cerhan, L. Joseph Melton, III, S. Vincent Rajkumar

Blood (2010) 116 (12): 2019–2025.

https://doi.org/10.1182/blood-2010-04-277566

Published: 2010

Includes: Supplemental data

Journal Articles

Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance

Celine M. Vachon, Robert A. Kyle, Terry M. Therneau, Barbara J. Foreman, Dirk R. Larson, Colin L. Colby, Tara K. Phelps, Angela Dispenzieri, Shaji K. Kumar, Jerry A. Katzmann, S. Vincent Rajkumar

Blood (2009) 114 (4): 785–790.

https://doi.org/10.1182/blood-2008-12-192575

Published: 2009

Journal Articles

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

Angela Dispenzieri, Robert A. Kyle, Jerry A. Katzmann, Terry M. Therneau, Dirk Larson, Joanne Benson, Raynell J. Clark, L. Joseph Melton, III, Morie A. Gertz, Shaji K. Kumar, Rafael Fonseca, Diane F. Jelinek, S. Vincent Rajkumar

Blood (2008) 111 (2): 785–789.

https://doi.org/10.1182/blood-2007-08-108357

Published: 2008

Journal Articles

Monoclonal Gammopathy of Undetermined Significance: Estimated Incidence and Duration Prior to Recognition.

Robert A. Kyle, Terry M. Therneau, Lee J. Melton, III, Angela Dispenzieri, Dirk R. Larson, Joanne T. Benson, Jerry A. Katzmann, S. Vincent Rajkumar

Blood (2007) 110 (11): 246.

https://doi.org/10.1182/blood.V110.11.246.246

Published: 2007

Journal Articles

Immunoglobulin free light chains and solitary plasmacytoma of bone

David Dingli, Robert A. Kyle, S. Vincent Rajkumar, Grzegorz S. Nowakowski, Dirk R. Larson, John P. Bida, Morie A. Gertz, Terry M. Therneau, L. Joseph Melton, III, Angela Dispenzieri, Jerry A. Katzmann

Blood (2006) 108 (6): 1979–1983.

https://doi.org/10.1182/blood-2006-04-015784

Published: 2006

Journal Articles

Immunoglobulin Free Light Chains at Diagnosis: Predictors of Progression and Survival in Solitary Plasmacytoma of Bone.

David Dingli, MD, PhD, Robert A. Kyle, MD, Vincent S. Rajkumar, MD, Grzegorz S. Nowakowski, MD, Dirk R. Larson, MS, John P. Bida, MA, Morie A. Gertz, MD, Angela Dispenzieri, MD, L. J. Melton, III, MD, Terry M. Therneau, PhD, Jerry A. Katzmann, PhD

Blood (2005) 106 (11): 5080.

https://doi.org/10.1182/blood.V106.11.5080.5080

Published: 2005

Journal Articles

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

S. Vincent Rajkumar, Robert A. Kyle, Terry M. Therneau, L. Joseph Melton, III, Arthur R. Bradwell, Raynell J. Clark, Dirk R. Larson, Matthew F. Plevak, Angela Dispenzieri, Jerry A. Katzmann

Blood (2005) 106 (3): 812–817.

https://doi.org/10.1182/blood-2005-03-1038

Published: 2005

Journal Articles

Presence of an Abnormal Serum Free Light Ratio Is an Independent Risk Factor for Progression in Monoclonal Gammopathy of Undetermined Significance (MGUS).

S. Vincent Rajkumar, MD, Robert A. Kyle, MD, Terry M. Therneau, PhD, L. Joseph Melton, III, MD, Arthur R. Bradwell, MB ChB, Raynell J. Clark, Dirk R. Larson, Matthew F. Plevak, Jerry A. Katzmann, PhD

Blood (2004) 104 (11): 3647.

https://doi.org/10.1182/blood.V104.11.3647.3647

Published: 2004

Journal Articles

Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

Blood (2004) 104 (6): 1881–1887.

https://doi.org/10.1182/blood-2004-01-0390

Published: 2004

Journal Articles

Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study

Blood (2004) 103 (10): 3960–3963.

https://doi.org/10.1182/blood-2003-12-4192

Published: 2004

Journal Articles

Long-term follow-up of IgM monoclonal gammopathy of undetermined significance

Robert A. Kyle, Terry M. Therneau, S. Vincent Rajkumar, Ellen D. Remstein, Janice R. Offord, Dirk R. Larson, Matthew F. Plevak, L. Joseph Melton, III

Blood (2003) 102 (10): 3759–3764.

https://doi.org/10.1182/blood-2003-03-0801

Published: 2003

Journal Articles

POEMS syndrome: definitions and long-term outcome: Presented in abstract form at the 41st annual meeting of the American Society of Hematology, New Orleans, LA, December 3-7, 1999.

Angela Dispenzieri, Robert A. Kyle, Martha Q. Lacy, S. Vincent Rajkumar, Terry M. Therneau, Dirk R. Larson, Philip R. Greipp, Thomas E. Witzig, Rita Basu, Guillermo A. Suarez, Rafael Fonseca, John A. Lust, Morie A. Gertz

Blood (2003) 101 (7): 2496–2506.

https://doi.org/10.1182/blood-2002-07-2299

Published: 2003

Journal Articles

A high bone marrow plasma cell labeling index in stable plateau–phase multiple myeloma is a marker for early disease progression and death: Presented in abstract form at the 36th Annual Meeting of the American Society of Clinical Oncology, New Orleans, Louisiana, May 20-23, 2000.

David P. Steensma, Morie A. Gertz, Philip R. Greipp, Robert A. Kyle, Martha Q. Lacy, John A. Lust, Janice R. Offord, Matthew F. Plevak, Terry M. Therneau, Thomas E. Witzig

Blood (2001) 97 (8): 2522–2523.

https://doi.org/10.1182/blood.V97.8.2522

Published: 2001

Journal Articles

Long-Term Survival (10 Years or More) in 30 Patients With Primary Amyloidosis

Robert A. Kyle, Morie A. Gertz, Philip R. Greipp, Thomas E. Witzig, John A. Lust, Martha Q. Lacy, Terry M. Therneau

Blood (1999) 93 (3): 1062–1066.

https://doi.org/10.1182/blood.V93.3.1062

Published: 1999

NARROW

Idiopathic Bence Jones Proteinuria (Smoldering Monoclonal Light-Chain Proteinuria): Clinical Course and Prognosis

Progression in smoldering Waldenström macroglobulinemia: long-term results

Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications

Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

Monoclonal Gammopathy of Undetermined Significance: Estimated Incidence and Duration Prior to Recognition.

Immunoglobulin free light chains and solitary plasmacytoma of bone

Immunoglobulin Free Light Chains at Diagnosis: Predictors of Progression and Survival in Solitary Plasmacytoma of Bone.

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

Presence of an Abnormal Serum Free Light Ratio Is an Independent Risk Factor for Progression in Monoclonal Gammopathy of Undetermined Significance (MGUS).

Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study

Long-term follow-up of IgM monoclonal gammopathy of undetermined significance

POEMS syndrome: definitions and long-term outcome: Presented in abstract form at the 41st annual meeting of the American Society of Hematology, New Orleans, LA, December 3-7, 1999.

A high bone marrow plasma cell labeling index in stable plateau–phase multiple myeloma is a marker for early disease progression and death: Presented in abstract form at the 36th Annual Meeting of the American Society of Clinical Oncology, New Orleans, Louisiana, May 20-23, 2000.

Long-Term Survival (10 Years or More) in 30 Patients With Primary Amyloidosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only